For the year ending 2025-12-31, CV had $650K increase in cash & cash equivalents over the period. -$22,954K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -25,315 |
| Depreciation and amortization | 216 |
| Loss on disposal of property and equipment | -1 |
| Amortization of operating lease right-of-use assets | 351 |
| Unrealized foreign exchange (gains) losses | 173 |
| Stock in lieu of debt repayment | 31 |
| Stock-based compensation | 826 |
| Bad debt expense | 11 |
| Accounts receivable | 478 |
| Inventory | 358 |
| Prepaid expenses and other current assets | 174 |
| Other long-term assets | 0 |
| Accounts payable | 376 |
| Accrued expenses and other current liabilities | 2,128 |
| Deferred revenue | 45 |
| Operating lease liabilities | -351 |
| Net cash used in operating activities | -22,864 |
| Purchases of property and equipment | 90 |
| Net cash used in investing activities | -90 |
| Proceeds from issuance of series h convertible preferred stock | 0 |
| Proceeds from ipo, net of commissions | 26,557 |
| Payment of ipo offering costs | 3,184 |
| Proceeds from promissory note issuance | 1,000 |
| Repayment of promissory note | 1,000 |
| Proceeds from exercises of options on common stock and warrants | 231 |
| Net cash provided by financing activities | 23,604 |
| Net increase (decrease) in cash and cash equivalents | 650 |
| Effect of exchange rate changes on cash and cash equivalents | 143 |
| Cash and cash equivalents at beginning of period | 9,319 |
| Cash and cash equivalents at end of year | 10,112 |
CapsoVision, Inc (CV)
CapsoVision, Inc (CV)